Novo Nordisk | NVO - Current Assets



Novo Nordisk reported DKK174.4B in Current Assets for its fiscal quarter ending in March of 2025.


Current Assets Change Date
ANI Pharmaceuticals USD 602.63M 66.34M Jun/2025
Aurora Cannabis CAD 465.3M 28.91M Jun/2025
Bausch Health Companies USD 6.51B 782M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Canopy Growth CAD 303.36M 37.72M Jun/2025
Corcept Therapeutics USD 443.11M 4.61M Jun/2025
Drreddys Laboratories INR 269.9B 16.88B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Merck USD 37.07B 1.56B Jun/2025
Novartis USD 25.94B 831M Jun/2025
Novo Nordisk 162.71B 11.69B Jun/2025
Novo Nordisk DKK 174.4B 20.76B Mar/2025
Pacira USD 745.61M 14.35M Jun/2025
Perrigo USD 2.62B 82M Jun/2025
Prestige Brands USD 480.52M 32.19M Jun/2025
Sanofi 37.02B 7B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025
Zoetis USD 5.92B 46M Jun/2025